IOSP (Innospec) EPS without NRI: $4.93 (TTM As of Mar. 2026)


IOSP Innospec Inc IOSP
76 GF Score
Price $83.11
GF Value $94.74
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Innospec EPS without NRI?

Innospec IOSP +1.63% 76 EPS without NRI is $4.93 as of Mar. 2026. GuruFocus rates IOSP with a GF Score™ of 76/100 and a GF Value™ of $94.74 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,257 Chemicals companies, Innospec ranks worse than 53.94% on this metric.

Innospec's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $1.05. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $4.93.

During the past 12 months, Innospec's average earnings per share (NRI) Growth Rate was -9.80% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -4.40% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 8.90% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Innospec's EPS without NRI or its related term are showing as below:

IOSP' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -53   Med: 5.2   Max: 112.4
Current: -4.4

During the past 13 years, Innospec's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 112.40% per year. The lowest was -53.00% per year. And the median was 5.20% per year.

IOSP's 3-Year EPS without NRI Growth Rate is ranked worse than
53.94% of 1257 companies
in the Chemicals industry
Industry Median: -1.7 vs IOSP: -4.40

Innospec's EPS (Diluted) for the three months ended in Mar. 2026 was $1.22. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $4.59.

Innospec's EPS (Basic) for the three months ended in Mar. 2026 was $1.23. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $4.60.


Innospec  (NAS:IOSP) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Innospec EPS without NRI Related Terms


Innospec EPS without NRI Historical Data

* Premium members only.

The historical data trend for Innospec's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innospec EPS without NRI Chart

Innospec Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.80 6.04 5.45 5.92 5.27

Innospec Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.32 1.26 1.12 1.50 1.05

IOSP vs MTX, ODC, NGVT: EPS without NRI Comparison

For the Specialty Chemicals subindustry, Innospec's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innospec PE Ratio without NRI vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Innospec's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Innospec's PE Ratio without NRI falls into.


IOSP
76GF Score
Innospec Inc IOSP
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innospec EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $4.93 mean?
Innospec (IOSP) has a EPS without NRI of $4.93 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Innospec and its competitors. According to the industry distribution chart, Innospec ranks #678 out of 1257 companies in the Chemicals industry, placing it in the top 53.9%.
Is Innospec's EPS without NRI too high?
Innospec's current EPS without NRI is $4.93. Based on the distribution chart, Innospec ranks #678 out of 1257 companies in the Chemicals industry, which is below the industry midpoint. Overall, Innospec has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Innospec's EPS without NRI compare to MTX and ODC?
According to the Chemicals industry distribution chart, Innospec ranks #678 out of 1257 companies for EPS without NRI. This places Innospec in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Chemicals company?
A good EPS without NRI depends on the Chemicals industry context. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Innospec and its competitors. Innospec's current EPS without NRI is $4.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innospec stock overvalued right now?
Based on GuruFocus' analysis, Innospec (IOSP) is currently considered Modestly Undervalued. The stock's GF Value™ is $94.74, compared to a current price of $83.11 — trading 12.3% below its estimated fair value. The current EPS without NRI is $4.93. Innospec's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Innospec (IOSP), the current EPS without NRI is $4.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Innospec (IOSP) Overvalued in 2026?

Based on GuruFocus' analysis, Innospec stock appears to be undervalued. The current stock price of $83.11 is trading 12.3% below its estimated GF Value™ of $94.74. GuruFocus considers Innospec to be Modestly Undervalued.

Key valuation signals for IOSP:

  • EPS without NRI: $4.93
  • GF Value™: $94.74 vs. price of $83.11 (12.3% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the IOSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Innospec Business Description

Other Exchanges 0JAX:UKOCT:Germany
Address 8310 South Valley Highway, Suite 350, Englewood, CO, USA, 80112
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
76GF Score

Get the complete analysis for IOSP

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$83.11
Price
$94.74
GF Value